Education
About Us
Working with TipRanks
Follow Us
Curanex Pharmaceuticals Inc. (CURX)
NASDAQ:CURX
| Dec 24 | Dec 23 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 |
| Operating Income | $ -365.06K | $ -19.30K |
| EBITDA | $ -290.39K | $ -17.48K |
| Net Income | $ -361.51K | $ -19.20K |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ 148.89K | $ 74.37K |
| Total Assets | $ 517.93K | $ 74.37K |
| Total Debt | $ 0.00 | $ 0.00 |
| Net Debt | $ -148.89K | $ -74.37K |
| Total Liabilities | $ 14.57K | $ 14.28K |
| Stockholders' Equity | $ 503.36K | $ 60.09K |
| Cash Flow | ||
| Free Cash Flow | $ -555.58K | $ -120.00 |
| Operating Cash Flow | $ -555.58K | $ -120.00 |
| Investing Cash Flow | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 630.10K | $ 72.06K |
Curanex Pharmaceuticals Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.